Article 2022 · 0 citations

mFOLFOX-based Chemotherapy Can Augment Survival in Advanced Gastric Cancer Patient with Disseminated Intravascular Coagulation

Aldemir, M. N., Turkeli, M., Simsek, M., Cayir, K., Yildirim, N., Bilici, N. M., Ayan, A. K., Tekin, S. B.

Abstract

Although gastric cancer is a frequent cancer type, disseminated intravascular coagulation is a very rare but serious complication of this disease. We report a 65-year-old man who complained of weight loss, nausea and vomiting, fatigue and dyspnoea for three days. He was diagnosed as having advanced gastric cancer complicated with disseminated intravascular coagulation, which was successfully treated with mFOLFOX chemotherapy regimen. After one cycle of mFOLFOX therapy, thrombocytopenia was improved and serum lactate dehydrogenase levels decreased. Remarkable remission was seen. After 12 cycles of chemotherapy, remarkable remission was seen in the primary tumour and multiple metastatic bone lesions.

Keywords

Advanced gastric cancer disseminated intravascular coagulation mFOLFOX-based chemotherapy 5-FLUOROURACIL

WoS Categories

Medicine, General & Internal

Sustainable Development Goals

Good Health and Well-being

Citation

Journal: WEST INDIAN MEDICAL JOURNAL
Year: 2022
Volume: 69
Issue: 7
Pages: 520-522
ISSN: 0043-3144
eISSN: 2309-5830
DOI: 10.7727/wimj.2015.271
WoS UID: WOS:000794032100011

Open via DOI